Related Experiment Video
Updated: Jun 16, 2026

Operational and Intervention Effects of Targeted Tuina in Lumbar Intervertebral Disc Degeneration Model Rabbits
Published on: July 21, 2023
The Effects of TWEAK, Fn14, and TGF-beta1 on Degeneration of Human Intervertebral Disc
Hoon Huh1, Yong-Jik Lee, Jung-Hee Kim
1Department of Neurosurgery, Medical Institute, Seoul Medical Center, Seoul, Korea.
Objective:
The purpose of this study is to explain the effect and reciprocal action among tumor necrosis factor (TNF) like weak inducer of apoptosis (TWEAK), fibroblast growth factor-inducible 14 (Fn14), and transforming growth factor-beta1 (TGF-beta1) on degeneration of human intervertebral disc (IVD).
Methods:
Human intervertebral disc tissues and cells were cultured with Dulbecco's Modified Eagle's Medium/Nutrient F-12 Ham (DMEM/F-12) media in 37, 5% CO(2) incubator. When IVD tissues were cultured with TWEAK, Fn14 that is an antagonistic receptor for TWEAK and TGF-beta1, the level of sulfated glycosaminoglycan (sGAG) was estimated by dimethyl methyleneblue (DMMB) assay and sex determining region Y (SRY)-box 9 (Sox9) and versican messenger ribonucleic acid (mRNA) levels were estimated by reverse transcriptase polymerase chain reaction (RT-PCR).
Results:
When human IVD tissue was cultured for nine days, the sGAG content was elevated in proportion to culture duration. The sGAG was decreased significantly by TWEAK 100 ng/mL, however, Fn14 500 ng/mL did not change the sGAG production of IVD tissue. The Fn14 increased versican and Sox9 mRNA levels decreased with TWEAK in IVD tissue TGF-beta1 20 ng/mL elevated the sGAG concentration 40% more than control. The sGAG amount decreased with TWEAK was increased with Fn14 or TGF-beta1 but the result was insignificant statistically. TGF-beta1 increased the Sox9 mRNA expression to 180% compared to control group in IVD tissue. Sox9 and versican mRNA levels decreased by TWEAK were increased with TGF-beta1 in primary cultured IVD cells, however, Fn14 did not show increasing effect on Sox9 and versican.
Conclusion:
This study suggests that TWEAK would act a role in intervertebral disc degeneration through decreasing sGAG and the mRNA level of versican and Sox9.
Insights
Tumor necrosis factor (TNF) like weak inducer of apoptosis (TWEAK) significantly decreases sulfated glycosaminoglycan (sGAG) and key gene expression in human intervertebral disc (IVD) degeneration. Fibroblast growth factor-inducible 14 (Fn14) and transforming growth factor-beta1 (TGF-beta1) partially counteract TWEAK's effects.
Area of Science:
- Biochemistry
- Cell Biology
- Biomedical Engineering
Background:
- Intervertebral disc (IVD) degeneration is a complex process.
- The roles of specific molecular mediators like TWEAK, Fn14, and TGF-beta1 in IVD degeneration require further elucidation.
Purpose of the Study:
- To investigate the effects of tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK), fibroblast growth factor-inducible 14 (Fn14), and transforming growth factor-beta1 (TGF-beta1) on human IVD degeneration.
- To understand the reciprocal actions of these factors in modulating IVD cellular and matrix components.
Main Methods:
- Human IVD tissues and cells were cultured in vitro.
- Levels of sulfated glycosaminoglycan (sGAG) were measured using dimethyl methyleneblue (DMMB) assay.
- Messenger RNA (mRNA) levels of sex determining region Y (SRY)-box 9 (Sox9) and versican were quantified via reverse transcriptase polymerase chain reaction (RT-PCR).
Main Results:
- TWEAK significantly decreased sGAG content and mRNA levels of versican and Sox9 in IVD tissues.
- TGF-beta1 increased sGAG concentration and Sox9 mRNA expression.
- Fn14 did not significantly alter sGAG production but showed a trend towards increasing sGAG and gene expression when combined with TGF-beta1.
Conclusions:
- TWEAK plays a role in intervertebral disc degeneration by reducing sGAG and key matrix gene expression.
- TGF-beta1 may have protective effects, partially counteracting TWEAK-induced degeneration.
- Further research is needed to fully understand the therapeutic potential of modulating these pathways in IVD disorders.
Related Concept Videos
Degenerative Disc Disease I: Introduction
Degenerative Disc Disease ll: Pathophysiology
Herniated Intervertebral Disc l: Introduction
TGF - β Signaling Pathway

